License Following Expiration. Upon expiration of the Royalty Term, the license granted to Fujisawa under Article 3 shall thereafter become irrevocable, royalty-free and fully paid up.
Appears in 2 contracts
Sources: Collaboration and License Agreement (Cardiome Pharma Corp), Collaboration and License Agreement (Cardiome Pharma Corp)